The impact of sarcopenia on survival and complications in surgical oncology: A review of the current literature

Journal of Surgical Oncology

Volumn 112, Issue 5, 2015, Pages 503-509

  Joglekar, Savita ^a   Nau, Peter N ^a   Mezhir, James J ^a  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

adenocarcinoma; complications; sarcopenia; survival

Indexed keywords

CANCER PATIENT; CANCER PROGNOSIS; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; IMAGE ANALYSIS; MANAGED CARE; MEDLINE; MUSCLE STRENGTH; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOPEDIC SURGERY; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SARCOPENIA; SURGICAL MORTALITY; SURVIVAL RATE; SYSTEMATIC REVIEW; TIME TO TREATMENT; COMPLICATION; MORTALITY; NEOPLASMS; PATHOLOGY; PROGNOSIS;

HUMANS; NEOPLASMS; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; SARCOPENIA; SURVIVAL RATE;

EID: 84945462792     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.24025     Document Type: Review

References (52)

1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al.,: Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010; 39: 412-423.
2. Fairchild B, Webb TP, Xiang Q, et al.,: Sarcopenia and frailty in elderly trauma patients. World J Surg 2015; 39: 373-379.
3. Du Y, Karvellas CJ, Baracos V, et al.,: Sarcopenia is a predictor of outcomes in very elderly patients undergoing emergency surgery. Surgery 2014; 156: 521-527.
4. Prado CM, Wells JC, Smith SR, et al.,: Sarcopenic obesity: A critical appraisal of the current evidence. Clin Nutr 2012; 31: 583-601.
5. Chung JY, Kang HT, Lee DC, et al.,: Body composition and its association with cardiometabolic risk factors in the elderly: A focus on sarcopenic obesity. Arch Gerontol Geriatr 2013; 56: 270-278.
6. Ormsbee MJ, Prado CM, Ilich JZ, et al.,: Osteosarcopenic obesity: The role of bone, muscle, and fat on health. J Cachexia Sarcopenia Muscle 2014; 5: 183-192.
7. Prado CM, Birdsell LA, Baracos VE,: The emerging role of computerized tomography in assessing cancer cachexia. Curr Opin Support Palliat Care 2009; 3: 269-275.
8. Roubenoff R, Hughes VA,: Sarcopenia: Current concepts. J Gerontol A Biol Sci Med Sci 2000; 55: M716-M724.
9. Prado CM, Baracos VE, McCargar LJ, et al.,: Sarcopenia as a determinant of chemotherapy toxicity and time to tumor progression in metastatic breast cancer patients receiving capecitabine treatment. Clin Cancer Res 2009; 15: 2920-2926.
10. Antoun S, Baracos VE, Birdsell L, et al.,: Low body mass index and sarcopenia associated with dose-limiting toxicity of sorafenib in patients with renal cell carcinoma. Ann Oncol 2010; 21: 1594-1598.
11. Dodson RM, Firoozmand A, Hyder O, et al.,: Impact of sarcopenia on outcomes following intra-arterial therapy of hepatic malignancies. J Gastrointest Surg 2013; 17: 2123-2132.
12. Antoun S, Birdsell L, Sawyer MB, et al.,: Association of skeletal muscle wasting with treatment with sorafenib in patients with advanced renal cell carcinoma: Results from a placebo-controlled study. J Clin Oncol 2010; 28: 1054-1060.
13. Miyamoto Y, Baba Y, Sakamoto Y, et al.,: Sarcopenia is a negative prognostic factor after curative resection of colorectal cancer. Ann Surg Oncol 2015; 22: 2663-2668.
14. Reisinger KW, van Vugt JL, Tegels JJ, et al.,: Functional compromise reflected by sarcopenia, frailty, and nutritional depletion predicts adverse postoperative outcome after colorectal cancer surgery. Ann Surg 2015; 261: 345-352.
15. Sabel MS, Terjimanian M, Conlon AS, et al.,: Analytic morphometric assessment of patients undergoing colectomy for colon cancer. J Surg Oncol 2013; 108: 169-175.
16. Peng PD, van Vledder MG, Tsai S, et al.,: Sarcopenia negatively impacts short-term outcomes in patients undergoing hepatic resection for colorectal liver metastasis. HPB (Oxford) 2011; 13: 439-446.
17. Ida S, Watanabe M, Yoshida N, et al.,: Sarcopenia is a predictor of postoperative respiratory complications in patients with esophageal cancer. Ann Surg Oncol 2015; PMID 25862583.
18. Harimoto N, Shirabe K, Yamashita YI, et al.,: Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma. Br J Surg 2013; 100: 1523-1530.
19. Iritani S, Imai K, Takai K, et al.,: Skeletal muscle depletion is an independent prognostic factor for hepatocellular carcinoma. J Gastroenterol 2015; 50: 323-332.
20. Sabel MS, Lee J, Cai S, et al.,: Sarcopenia as a prognostic factor among patients with stage III melanoma. Ann Surg Oncol 2011; 18: 3579-3585.
21. Joglekar S, Asghar A, Mott SL, et al.,: Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma. J Surg Oncol 2015; 111: 771-775.
22. Peng P, Hyder O, Firoozmand A, et al.,: Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma. J Gastrointest Surg 2012; 16: 1478-1486.
23. Okumura S, Kaido T, Hamaguchi Y, et al.,: Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer. Surgery 2015; 157: 1088-1098.
24. Smith AB, Deal AM, Yu H, et al.,: Sarcopenia as a predictor of complications and survival following radical cystectomy. J Urol 2014; 191: 1714-1720.
25. Psutka SP, Carrasco A, Schmit GD, et al.,: Sarcopenia in patients with bladder cancer undergoing radical cystectomy: Impact on cancer-specific and all-cause mortality. Cancer 2014; 120: 2910-2918.
26. Wan F, Zhu Y, Gu C, et al.,: Lower skeletal muscle index and early complications in patients undergoing radical cystectomy for bladder cancer. World J Surg Oncol 2014; 12: 14.
27. Tan BH, Birdsell LA, Martin L, et al.,: Sarcopenia in an overweight or obese patient is an adverse prognostic factor in pancreatic cancer. Clin Cancer Res 2009; 15: 6973-6979.
28. Friedman J, Lussiez A, Sullivan J, et al.,: Implications of sarcopenia in major surgery. Nutr Clin Pract 2015; 30: 175-179.
29. Englesbe MJ, Lee JS, He K, et al.,: Analytic morphomics, core muscle size, and surgical outcomes. Ann Surg 2012; 256: 255-261.
30. Lieffers JR, Bathe OF, Fassbender K, et al.,: Sarcopenia is associated with postoperative infection and delayed recovery from colorectal cancer resection surgery. Br J Cancer 2012; 107: 931-936.
31. Lee JS, Terjimanian MN, Tishberg LM, et al.,: Surgical site infection and analytic morphometric assessment of body composition in patients undergoing midline laparotomy. J Am Coll Surg 2011; 213: 236-244.
32. Englesbe MJ, Patel SP, He K, et al.,: Sarcopenia and mortality after liver transplantation. J Am Coll Surg 2010; 211: 271-278.
33. Englesbe MJ, Terjimanian MN, Lee JS, et al.,: Morphometric age and surgical risk. J Am Coll Surg 2013; 216: 976-985.
34. Baumgartner RN, Koehler KM, Gallagher D, et al.,: Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998; 147: 755-763.
35. Prado CM, Lieffers JR, McCargar LJ, et al.,: Prevalence and clinical implications of sarcopenic obesity in patients with solid tumours of the respiratory and gastrointestinal tracts: A population-based study. Lancet Oncol 2008; 9: 629-635.
36. Baracos VE, Reiman T, Mourtzakis M, et al.,: Body composition in patients with non-small cell lung cancer: A contemporary view of cancer cachexia with the use of computed tomography image analysis. Am J Clin Nutr 2010; 91: 1133S-1137S.
37. Tyagi M, Bukrinsky M,: Human immunodeficiency virus (HIV) latency: The major hurdle in HIV eradication. Mol Med 2012; 18: 1096-1108.
38. van Vugt JL, Braam HJ, van Oudheusden TR, et al.,: Skeletal muscle depletion is associated with severe postoperative complications in patients undergoing cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal cancer. Ann Surg Oncol 2015; PMID 25672564.
39. Grobmyer SR, Pieracci FM, Allen PJ, et al.,: Defining morbidity after pancreaticoduodenectomy: Use of a prospective complication grading system. J Am Coll Surg 2007; 204: 356-364.
40. Bassi C, Dervenis C, Butturini G, et al.,: Postoperative pancreatic fistula: An international study group (ISGPF) definition. Surgery 2005; 138: 8-13.
41. Mezhir JJ,: Management of complications following pancreatic resection: An evidence-based approach. J Surg Oncol 2013; 107: 58-66.
42. Clavien PA, Barkun J, de Oliveira ML, et al.,: The Clavien-Dindo classification of surgical complications: Five-year experience. Ann Surg 2009; 250: 187-196.
43. Lodewick TM, van Nijnatten TJ, van Dam RM, et al.,: Are sarcopenia, obesity and sarcopenic obesity predictive of outcome in patients with colorectal liver metastases? HPB (Oxford) 2015; 17: 438-446.
44. Dale W, Hemmerich J, Kamm A, et al.,: Geriatric assessment improves prediction of surgical outcomes in older adults undergoing pancreaticoduodenectomy: A prospective cohort study. Ann Surg 2014; 259: 960-965.
45. Hanna JS,: Sarcopenia and critical illness: A deadly combination in the elderly. JPEN J Parenter Enteral Nutr 2015; 39: 273-281.
46. Gibson DJ, Burden ST, Strauss BJ, et al.,: The role of computed tomography in evaluating body composition and the influence of reduced muscle mass on clinical outcome in abdominal malignancy: A systematic review. Eur J Clin Nutr 2015; 18.
47. Aslani A, Gill AJ, Roach PJ, et al.,: Preoperative body composition is influenced by the stage of operable pancreatic adenocarcinoma but does not predict survival after Whipple's procedure. HPB (Oxford) 2010; 12: 325-333.
48. Wigmore SJ, Plester CE, Richardson RA, et al.,: Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer 1997; 75: 106-109.
49. Sadot E, Doussot A, O'Reilly EM, et al.,: FOLFIRINOX induction therapy for stage 3 pancreatic adenocarcinoma. Ann Surg Oncol 2015; PMID 26065868.
50. Arvold ND, Ryan DP, Niemierko A, et al.,: Long-term outcomes of neoadjuvant chemotherapy before chemoradiation for locally advanced pancreatic cancer. Cancer 2012; 118: 3026-3035.
51. Collins JT, Noble S, Chester J, et al.,: Association of sarcopenia and observed physical performance with attainment of multidisciplinary team planned treatment in non-small cell lung cancer: An observational study protocol. BMC Cancer 2015; 15: 544.
52. Paddon-Jones D, R asmussen BB,: Dietary protein recommendations and the prevention of sarcopenia. Curr Opin Clin Nutr Metab Care 2009; 12: 86-90.